A look at the effectiveness of oral Wegovy for weight loss, following the US approval of the daily pill version of semaglutide.
Recap by typeshit. Full story at www.polskieradio.pl.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
17:54
Dr. Stirrett weighs the two drugs against each other for people over 50 trying to lose weight.
The FDA says retatrutide falls one alpha amino acid short. A biologic label would mean 12 years of exclusivity instead of 5, a later Medicare price clock and no compounding.
Loading…